BamSEC and AlphaSense Join Forces
Learn More

Horizon Therapeutics Plc

Formerly NASDAQ: HZNP
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 213 pages Recitals
12/34/56
EX-10.1
from 10-Q 3 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That Horizon Therapeutics Plc Treats as Private or Confidential Amendment No. 10 to the License Agreement Remainder of This Page Intentionally Left Blank
12/34/56
EX-10
from 10-K 5 pages Excise Tax Gross-Up Agreement
12/34/56
EX-10
from 10-K 2 pages [•], 2022 [Name] [Address] Re: Retention Bonus Agreement Dear [•]
12/34/56
EX-10
from 10-K 84 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That Horizon Therapeutics Plc Treats as Private or Confidential License Agreement
12/34/56
EX-10
from 10-K 2 pages Horizon Therapeutics Public Limited Company Non-Employee Director Compensation Policy Amended Effective: October 26, 2022
12/34/56
EX-10.6
from 10-Q 3 pages Amendment No. 4 to Commercial Supply Agreement
12/34/56
EX-10.5
from 10-Q 18 pages Executive Employment Agreement by and Between Horizon Therapeutics Plc and Horizon Therapeutics USA, Inc. and Jacopo Leonardi
12/34/56
EX-10.4
from 10-Q 9 pages Executive Employment and Transition Agreement
12/34/56
EX-10.3
from 10-Q 18 pages Executive Employment Agreement by and Between Horizon Therapeutics Plc and Horizon Therapeutics USA, Inc. and Aaron L. Cox
12/34/56
EX-10.4
from 10-Q 2 pages Horizon Therapeutics Public Limited Company Non-Employee Director Compensation Policy Amended Effective: April 28, 2022
12/34/56
EX-10.66
from 10-K 18 pages Executive Employment Agreement by and Between Horizon Therapeutics Plc and Horizon Therapeutics USA, Inc. and Sean Clayton
12/34/56
EX-10.65
from 10-K 3 pages Release and Waiver of Claims
12/34/56
EX-10.64
from 10-K 4 pages Release and Waiver of Claims
12/34/56
EX-10.63
from 10-K 48 pages Master Manufacturing Services Agreement October 15, 2018
12/34/56
EX-10.62
from 10-K 31 pages Horizon Therapeutics Public Limited Company Amended and Restated 2018 Equity Incentive Plan
12/34/56
EX-10.52
from 10-K 53 pages Horizon Therapeutics Public Limited Company Amended and Restated 2020 Equity Incentive Plan
12/34/56
EX-10.3
from 10-K 2 pages Horizon Therapeutics Public Limited Company Non-Employee Director Compensation Policy Amended Effective: October 28, 2021
12/34/56
EX-10.3
from 10-Q 43 pages Horizon Therapeutics Public Limited Company 2014 Non-Employee Equity Plan
12/34/56
EX-10.2
from 10-Q 29 pages Horizon Therapeutics Public Limited Company Amended and Restated 2018 Equity Incentive Plan
12/34/56